On Monday, Japanese drug maker Eisai Inc. filed a lawsuit against the DEA in the District of Columbia Court of Appeals.  Their complaint?  Eisai created a drug, called Fycompa, that the FDA approved last October to treat epileptic seizures.  Due to FDA’s scheduling recommendation and the drug’s effect on the central nervous system, the DEA…